ViiV Events

ViiV Events

by VIIV HEALTHCARE LIMITED

0 ratings
Free

Rating summary

Details

  • Released
  • Updated
  • August 22, 2023
  • June 12, 2026

Features

ViiV Events screenshot #1 for iPhone
ViiV Events screenshot #2 for iPhone
ViiV Events screenshot #3 for iPhone
ViiV Events screenshot #4 for iPhone
ViiV Events screenshot #5 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

The ViiV Events App is for Health Care Professionals, Allied Healthcare Professionals and ViiV Healthcare employees only who are involved in treating the relevant disease area covered in the meeting you are attending and contains promotional and non-promotional content. All relevant prescribing information for ViiV products will be available at the meeting and via the Resources Library within this app. Adverse events should be reported in accordance with local requirements. In the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Apple App store and Adverse events in the UK should also be reported to GlaxoSmithKline on 0800 221 441. For users of this App outside of the UK, please consult the local ViiV (or GSK website if ViiV is not located in your country) website for information on how to report a local adverse event. You can locate local adverse event reporting information here: www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/ ViiV Healthcare values your privacy. You can read about how we process your data and about your data privacy rights here: https://viivhealthcare.com/privacy-notice/ PM-GBL-HVX-MAPP-230001 Aug23
Show more

What's New in ViiV Events

3.0.0

June 12, 2026

We're excited to announce that the app now supports Apple's new Liquid Glass design system. Adjustments made to support the new workspace dashboard report called “Time spent in the app”, giving workspace managers clear visibility into how long each attendee actively used the app. When scheduling a meeting via the app, meeting organizers are no longer able to create new external participants that use the same email address as an existing participant. This is to prevent the accidental creation of duplicate participants.

More